251 related articles for article (PubMed ID: 26586358)
21. Heyde syndrome: a common but less recognized complex of aortic stenosis and bleeding intestinal angiodysplasia.
Hokama A; Kishimoto K; Higashiarakawa M; Chinen H; Kinjo F; Fujita J
South Med J; 2009 Dec; 102(12):1279. PubMed ID: 20016445
[No Abstract] [Full Text] [Related]
22. We always need a pulse, or do we??
Miller L
J Cardiovasc Transl Res; 2012 Jun; 5(3):296-301. PubMed ID: 22552969
[No Abstract] [Full Text] [Related]
23. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
24. Interventional Occlusion of Left Ventricular Assist Device Outflow Graft After Pump Thrombosis and Partial Myocardial Recovery.
Erkilet G; Westenfeld R; Saeed D
Artif Organs; 2015 Aug; 39(8):729-30. PubMed ID: 26234453
[No Abstract] [Full Text] [Related]
25. Treatment of Left Ventricular Assist Device Thrombosis: Single-Center Experience.
Beyazpınar DS; Ersoy Ö; Gültekin B; Aliyev A; Avsever M; Akay HT; Özkan M; Sezgin A; Aşlamacı S
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):165-167. PubMed ID: 29528019
[TBL] [Abstract][Full Text] [Related]
26. Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol.
Draper K; Kale P; Martin B; Kelly Cordero R; Ha R; Banerjee D
J Heart Lung Transplant; 2015 Jan; 34(1):132-134. PubMed ID: 25447569
[No Abstract] [Full Text] [Related]
27. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
Yates SW
Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
[TBL] [Abstract][Full Text] [Related]
28. Platelet inhibition with ticagrelor for left ventricular assist device thrombosis.
Oliveira GH; Al-Kindi SG; ElAmm C; Qattan MY; Deo S; Medalion B; Benatti RD; Osman MN; Ginwalla M; Park SJ; Simon DI
Circ Heart Fail; 2015 May; 8(3):649-51. PubMed ID: 25991808
[No Abstract] [Full Text] [Related]
29. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal bleeding and coagulation disorders in a patient with left-ventricular assist device.
Correale M; Ieva R; Pappalardo F; Santoro F; De Bonis M; Di Biase M
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):173-4. PubMed ID: 23303312
[No Abstract] [Full Text] [Related]
31. Science for surgeons: understanding pump thrombogenesis in continuous-flow left ventricular assist devices.
de Biasi AR; Manning KB; Salemi A
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):667-73. PubMed ID: 25534307
[No Abstract] [Full Text] [Related]
32. Outflow graft thrombectomy during HeartMate II left ventricular assist device exchange.
Berg KB; Klodell CT
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):714-5. PubMed ID: 25006211
[TBL] [Abstract][Full Text] [Related]
33. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.
Schurr JW; Seifert FC; McLarty AJ
Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625
[TBL] [Abstract][Full Text] [Related]
34. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
35. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
Strain J; Templeton K
S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
[No Abstract] [Full Text] [Related]
36. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
37. Apixaban: Alternative Anticoagulation for HeartMate 3 Ventricular Assist Device.
Whitehouse KR; Avula D; Kahlon T; Costelle D; Dunbar-Matos C; Pahwa S; Trivedi JR; Slaughter MS
ASAIO J; 2022 Mar; 68(3):318-322. PubMed ID: 35213879
[TBL] [Abstract][Full Text] [Related]
38. MY APPROACH to left ventricular assist device therapy.
Mehra MR
Trends Cardiovasc Med; 2015 Oct; 25(7):657-8. PubMed ID: 26398273
[No Abstract] [Full Text] [Related]
39. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lopes RD; Al-Khatib SM; Wallentin L; Yang H; Ansell J; Bahit MC; De Caterina R; Dorian P; Easton JD; Erol C; Ezekowitz JA; Gersh BJ; Granger CB; Hohnloser SH; Horowitz J; Hylek EM; McMurray JJ; Mohan P; Vinereanu D; Alexander JH
Lancet; 2012 Nov; 380(9855):1749-58. PubMed ID: 23036896
[TBL] [Abstract][Full Text] [Related]
40. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
